X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. TTK HEALTHCARE FDC LTD./
TTK HEALTHCARE
 
P/E (TTM) x 17.2 28.4 60.4% View Chart
P/BV x 3.6 5.2 68.3% View Chart
Dividend Yield % 1.3 0.6 238.3%  

Financials

 FDC LTD.   TTK HEALTHCARE
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TTK HEALTHCARE
Mar-14
FDC LTD./
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs144663 21.6%   
Low Rs79399 19.8%   
Sales per share (Unadj.) Rs47.6535.6 8.9%  
Earnings per share (Unadj.) Rs7.615.9 47.7%  
Cash flow per share (Unadj.) Rs9.020.0 45.0%  
Dividends per share (Unadj.) Rs2.254.00 56.3%  
Dividend yield (eoy) %2.00.8 268.6%  
Book value per share (Unadj.) Rs47.5137.6 34.5%  
Shares outstanding (eoy) m177.837.77 2,288.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.0 235.8%   
Avg P/E ratio x14.633.3 43.9%  
P/CF ratio (eoy) x12.326.5 46.5%  
Price / Book Value ratio x2.33.9 60.6%  
Dividend payout %29.625.1 117.9%   
Avg Mkt Cap Rs m19,7844,127 479.3%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m1,221607 201.2%   
Avg. sales/employee Rs ThNM2,436.7-  
Avg. wages/employee Rs ThNM355.2-  
Avg. net profit/employee Rs ThNM72.5-  
INCOME DATA
Net Sales Rs m8,4594,162 203.2%  
Other income Rs m39461 643.1%   
Total revenues Rs m8,8524,223 209.6%   
Gross profit Rs m2,070197 1,050.3%  
Depreciation Rs m24932 785.8%   
Interest Rs m3130 103.7%   
Profit before tax Rs m2,184197 1,110.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m60673 831.8%   
Profit after tax Rs m1,353124 1,092.1%  
Gross profit margin %24.54.7 516.8%  
Effective tax rate %27.737.0 74.9%   
Net profit margin %16.03.0 537.4%  
BALANCE SHEET DATA
Current assets Rs m4,3551,629 267.4%   
Current liabilities Rs m1,7921,058 169.4%   
Net working cap to sales %30.313.7 220.9%  
Current ratio x2.41.5 157.9%  
Inventory Days Days4430 149.3%  
Debtors Days Days2534 73.4%  
Net fixed assets Rs m3,025556 543.8%   
Share capital Rs m17978 229.9%   
"Free" reserves Rs m8,243878 938.5%   
Net worth Rs m8,4531,069 790.5%   
Long term debt Rs m11159 6.7%   
Total assets Rs m10,5572,399 440.0%  
Interest coverage x71.47.6 942.3%   
Debt to equity ratio x00.1 0.9%  
Sales to assets ratio x0.81.7 46.2%   
Return on assets %13.16.4 204.5%  
Return on equity %16.011.6 138.2%  
Return on capital %23.518.5 127.4%  
Exports to sales %13.30.8 1,683.5%   
Imports to sales %3.31.4 238.7%   
Exports (fob) Rs m1,12633 3,421.6%   
Imports (cif) Rs m28358 485.1%   
Fx inflow Rs m1,14633 3,483.6%   
Fx outflow Rs m35563 562.3%   
Net fx Rs m791-30 -2,610.8%   
CASH FLOW
From Operations Rs m1,485127 1,172.9%  
From Investments Rs m-620-146 424.3%  
From Financial Activity Rs m-75322 -3,436.1%  
Net Cashflow Rs m1133 4,512.0%  

Share Holding

Indian Promoters % 68.9 65.4 105.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 3.7 127.0%  
FIIs % 7.5 5.2 144.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 25.8 73.6%  
Shareholders   23,730 12,723 186.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  J.B.CHEMICALS  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - ALEMBIC PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS